254
Views
42
CrossRef citations to date
0
Altmetric
CASE REPORT

Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism

, MD, , , &
Pages 123-126 | Received 27 Mar 2006, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Giancarlo Logroscino, Bruno P. Imbimbo, Madia Lozupone, Rodolfo Sardone, Rosa Capozzo, Petronilla Battista, Chiara Zecca, Vittorio Dibello, Gianluigi Giannelli, Antonello Bellomo, Antonio Greco, Antonio Daniele, Davide Seripa & Francesco Panza. (2019) Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs. Expert Opinion on Pharmacotherapy 20:9, pages 1091-1107.
Read now
Lina Riedl, Ian R Mackenzie, Hans Förstl, Alexander Kurz & Janine Diehl-Schmid. (2014) Frontotemporal lobar degeneration: current perspectives. Neuropsychiatric Disease and Treatment 10, pages 297-310.
Read now
Edward C. Lauterbach, Preetha Sharone Kuppuswamy & Lauren L. Greenway. (2010) Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. Neurocase 16:5, pages 436-450.
Read now

Articles from other publishers (39)

Christine Le & Elizabeth Finger. (2021) Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia. CNS Drugs 35:10, pages 1081-1096.
Crossref
Leandro Boson Gambogi, Henrique Cerqueira Guimarães, Leonardo Cruz de Souza & Paulo Caramelli. (2021) Treatment of the behavioral variant of frontotemporal dementia: a narrative review. Dementia & Neuropsychologia 15:3, pages 331-338.
Crossref
Rita Khoury, Yu Liu, Quratulanne Sheheryar & George T. Grossberg. (2021) Pharmacotherapy for Frontotemporal Dementia. CNS Drugs 35:4, pages 425-438.
Crossref
A.N. Bogolepova, E.E. Vasenina, N.A. Gomzyakova, E.I. Gusev, N.G. Dudchenko, A.Yu. Emelin, N.M. Zalutskaya, R.I. Isaev, Yu.V. Kotovskaya, O.S. Levin, I.V. Litvinenko, V.Yu. Lobzin, M.Yu. Martynov, E.A. Mkhitaryan, G.N. Nikolay, E.I. Palchikova, O.N. Tkacheva, M.A. Cherdak, A.S. Chimagomedova & N.N. Yakhno. (2021) Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:10, pages 6.
Crossref
Martina Assogna, Elias Paolo Casula, Ilaria Borghi, Sonia Bonnì, Domenico Samà, Caterina Motta, Francesco Di Lorenzo, Alessia D’Acunto, Francesco Porrazzini, Marilena Minei, Carlo Caltagirone, Alessandro Martorana & Giacomo Koch. (2020) Effects of Palmitoylethanolamide Combined with Luteoline on Frontal Lobe Functions, High Frequency Oscillations, and GABAergic Transmission in Patients with Frontotemporal Dementia. Journal of Alzheimer's Disease 76:4, pages 1297-1308.
Crossref
Francesco Panza, Madia Lozupone, Davide Seripa, Antonio Daniele, Mark Watling, Gianluigi Giannelli & Bruno P. Imbimbo. (2020) Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. Nature Reviews Neurology 16:4, pages 213-228.
Crossref
Ya. B. Fedorova. (2019) Current approaches to the treatment of fronto-temporal dementia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:9, pages 18.
Crossref
I. V. Kolykhalov. (2018) Frontotemporal dementia in psychiatric practice: diagnostic and therapeutic aspects. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY:2, pages 109-115.
Crossref
S. Gazzina, M.A. Manes, A. Padovani & B. Borroni. (2017) Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies. European Journal of Pharmacology 817, pages 76-85.
Crossref
Hiroshi Nomoto, Yoichiro Matsubara, Yosuke Ichimiya & Heii Arai. (2017) A case of frontotemporal dementia with sexual disinhibition controlled by aripiprazole. Psychogeriatrics 17:6, pages 509-510.
Crossref
Eline Wauters, Kristel Sleegers, Marc Cruts & Christine Van Broeckhoven. 2017. Disease-Modifying Targets in Neurodegenerative Disorders. Disease-Modifying Targets in Neurodegenerative Disorders 199 249 .
Richard M. Tsai & Adam L. Boxer. (2016) Therapy and clinical trials in frontotemporal dementia: past, present, and future. Journal of Neurochemistry 138, pages 211-221.
Crossref
Shirley Y. Pang & Bruce L. Miller. 2016. The Behavioral Neurology of Dementia. The Behavioral Neurology of Dementia 143 155 .
Jutta Maria Birkhoff, Cesare Garberi & Laura Re. (2016) The behavioral variant of frontotemporal dementia: An analysis of the literature and a case report. International Journal of Law and Psychiatry 47, pages 157-163.
Crossref
Elizabeth C. Finger. (2016) Frontotemporal Dementias. CONTINUUM: Lifelong Learning in Neurology 22:2, Dementia, pages 464-489.
Crossref
David C. Perry & Howard J. Rosen. 2016. Non‐Alzheimer's and Atypical Dementia. Non‐Alzheimer's and Atypical Dementia 49 63 .
Sayantani Ghosh & Carol F. Lippa. (2013) Clinical Subtypes of Frontotemporal Dementia. American Journal of Alzheimer's Disease & Other Dementiasr 30:7, pages 653-661.
Crossref
Richard M. Tsai & Adam L. Boxer. 2016. Hodges' Frontotemporal Dementia. Hodges' Frontotemporal Dementia 243 261 .
. 2016. Hodges' Frontotemporal Dementia. Hodges' Frontotemporal Dementia 211 271 .
Nicholas T Bott, Anneliese Radke, Melanie L Stephens & Joel H Kramer. (2014) Frontotemporal dementia: diagnosis, deficits and management. Neurodegenerative Disease Management 4:6, pages 439-454.
Crossref
Richard M. Tsai & Adam L. Boxer. (2014) Treatment of Frontotemporal Dementia. Current Treatment Options in Neurology 16:11.
Crossref
Peter S. Pressman & Bruce L. Miller. (2014) Diagnosis and Management of Behavioral Variant Frontotemporal Dementia. Biological Psychiatry 75:7, pages 574-581.
Crossref
Jie Ren, Hefei Jiang, Juan Zhao, Wenqun Xin, Yuanyuan Xu, Xin Chen & Kun Hu. (2014) DMPPQA, a novel angiogenesis inhibitor, induces apoptosis in human colon cancer HCT-116 cells and HUVECs. Cell Biology International 38:3, pages 343-354.
Crossref
Mandana Modirrousta, Bruce H Price & Bradford C Dickerson. (2013) Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment. Neurodegenerative Disease Management 3:2, pages 133-146.
Crossref
Xinling Wang, Yuedi Shen & Wei Chen. (2012) Progress in Frontotemporal Dementia Research. American Journal of Alzheimer's Disease & Other Dementiasr 28:1, pages 15-23.
Crossref
Roy R. Reeves & Candace L. Perry. (2013) Aripiprazole for Sexually Inappropriate Vocalizations in Frontotemporal Dementia. Journal of Clinical Psychopharmacology 33:1, pages 145-146.
Crossref
K. Witt, G. Deuschl & T. Bartsch. (2012) Frontotemporale DemenzenFrontotemporal dementias. Der Nervenarzt 84:1, pages 20-32.
Crossref
Rachel E. Seltman & Brandy R. Matthews. (2012) Frontotemporal Lobar Degeneration. CNS Drugs 26:10, pages 841-870.
Crossref
Masood Manoochehri & Edward D. Huey. (2012) Diagnosis and Management of Behavioral Issues in Frontotemporal Dementia. Current Neurology and Neuroscience Reports 12:5, pages 528-536.
Crossref
Brian S. Rogers & Carol F. Lippa. (2012) A Clinical Approach to Early-Onset Inheritable Dementia. American Journal of Alzheimer's Disease & Other Dementiasr 27:3, pages 154-161.
Crossref
Tarik Karakaya, Fabian Fußer, David Prvulovic & Harald Hampel. (2012) Treatment Options for Tauopathies. Current Treatment Options in Neurology 14:2, pages 126-136.
Crossref
Lothar Burghaus, Carsten Eggers, Lars Timmermann, Gereon R. Fink & Nico J. Diederich. (2011) Hallucinations in Neurodegenerative Diseases. CNS Neuroscience & Therapeutics 18:2, pages 149-159.
Crossref
Gregory A. Jicha. (2011) Medical Management of Frontotemporal Dementias: The Importance of the Caregiver in Symptom Assessment and Guidance of Treatment Strategies. Journal of Molecular Neuroscience 45:3, pages 713-723.
Crossref
Gregory A Jicha & Peter T Nelson. (2011) Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options. Neurodegenerative Disease Management 1:2, pages 141-156.
Crossref
Robert Perneczky, Christian Sorg & Hans Förstl. 2010. Principles and Practice of Geriatric Psychiatry. Principles and Practice of Geriatric Psychiatry 28 35 .
Gil D. Rabinovici & Bruce L. Miller. (2010) Frontotemporal Lobar Degeneration. CNS Drugs 24:5, pages 375-398.
Crossref
Robert Perneczky, Corina Pohl, Susanne Bornschein, Hans Förstl, Alexander Kurz & Janine Diehl-Schmid. (2009) Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations. European Archives of Psychiatry and Clinical Neuroscience 259:6, pages 362-367.
Crossref
S. Jantová, A. Repický, S. Letašiová & L. Čipák. (2008) 4‐Amino‐3‐acetylquinoline‐induced apoptosis of murine L1210 leukemia cells involves ROS‐mitochondrial‐mediated death signaling and activation of p38 MAPK. Cell Biochemistry and Function 26:5, pages 609-619.
Crossref
Adam L. Boxer & Bradley F. Boeve. (2007) Frontotemporal Dementia Treatment: Current Symptomatic Therapies and Implications of Recent Genetic, Biochemical, and Neuroimaging Studies. Alzheimer Disease & Associated Disorders 21:4, pages S79-S87.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.